Theravance Biopharma aims to transform the treatment of serious diseases through the discovery and development of organ-selective medicines designed to maximize patient benefit while minimizing patient risk. Our research is focused in the areas of inflammation and immunology, and our pipeline of internally discovered programs is targeted to address significant patient needs.